Type 2

Two important studies on thiazolidinediones (TZDs), a class of insulin sensitizers, were published in November and December of 2006.&nbsp;

Clinical Trials: ADOPT and CHICAGO 

Type 1

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/article/6-dd_0.jpg?itok=IOTY2EZ5

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/article/6-dd_0.jpg?itok=i5JJe-j_

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/article/6-dd_0.jpg?itok=lS8dZ-Dh

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/article/6-dd_0.jpg?itok=j6qYFA2q

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/article/6-dd_0.jpg?itok=qjwwaU79

Diabetes Care in the United States – An Interview with Noted Cardiologist Dr. Steven Nissen

Noted cardiologist, Dr. Nissen on Avandia.

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/article/photo_conferencepearls_10_3_large_0.jpg?itok=opSOWkym

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/article/photo_conferencepearls_10_3_large_0.jpg?itok=wzBcPcSR

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/article/photo_conferencepearls_10_3_large_0.jpg?itok=z_k9Mb0v

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/article/photo_conferencepearls_10_3_large_0.jpg?itok=XoC3bXYC

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/article/photo_conferencepearls_10_3_large_0.jpg?itok=cRp6K5gW

American Diabetes Association 68th Scientific Sessions – San Francisco (June 6-10)

When every fifth taxi in downtown San Francisco is carrying an ad for Byetta, FlexPen, or FreeStyle meters, you know the American Diabetes Association (ADA) is in town.&nbsp;

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/article/avandia_2.jpg?itok=oDgJrPMU

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/article/avandia_2.jpg?itok=pzfTD1NI

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/article/avandia_2.jpg?itok=3EYeVLzL

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/article/avandia_2.jpg?itok=W8Ywd8gO

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/article/avandia_2.jpg?itok=QMspyOHU

Dismantling Avandia, Actos and the TZDs

Dismantling Avandia, Actos and TZDs.

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/article/accord_tall_hires.png?itok=EmBpoIqv

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/article/accord_tall_hires.png?itok=Gfvf1dp5

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/article/accord_tall_hires.png?itok=zF6uEzZG

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/article/accord_tall_hires.png?itok=BjYjtkqZ

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/article/accord_tall_hires.png?itok=tPnRK1gP

ACCORD, ADVANCE, and the VADT: What Do They Mean, and for Whom?

ACCORD, ADVANCE, and the VADT: What Do They Mean, And For Whom?

FDA Updates Warnings and Precautions Section of Actos Label after French and German Regulatory Authorities Suspend Drug Due to Possible Increased Risk of Bladder Cancer

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/article/2-conf_1.png?itok=Q447I6Et

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/article/2-conf_1.png?itok=fRagD6Gv

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/article/2-conf_1.png?itok=pUz8f0ld

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/article/2-conf_1.png?itok=4qrTGOYQ

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/article/2-conf_1.png?itok=6xIihdIe

conference pearls

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/article/24-dialogue_0.png?itok=8USjs0fi

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/article/24-dialogue_0.png?itok=RoCgtD6f

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/article/24-dialogue_0.png?itok=P0Uo0pbg

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/article/24-dialogue_0.png?itok=bnPqlo_E

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/article/24-dialogue_0.png?itok=bhwoQfy8

John Buse, MD, PhD Offers Wisdom, a Take on the ADA and FDA, and Weighs in on the Current Regulatory Environment  

Former ADA President Dr. John Buse offers a take on the ADA and FDA and weighs in on the current regulatory environment and healthcare reform.

entity.node.canonical

Mission

Who We Are

Programs

Events

Financials & Governance

Donate

News

Type 1 Diabetes

Type 2 Diabetes

Prediabetes

Gestational Diabetes

Diabetes Management

Diabetes Technology

Diabetes Medications

Diabetes Complications

Diabetes Research

Understanding Diabetes

Exercise

Mental Health

Diet and Nutrition

Lifestyle

Recipes

Wellness

Ways to Donate

Our Mission

Board of Directors

Staff

Impact Reports

Contact Us

About diaTribe

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/2023-08/pexels-anna-shvets-3683040.jpg?itok=nj2uBx5V

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/2023-08/pexels-anna-shvets-3683040.jpg?itok=KD1RsgS_

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/2023-08/pexels-anna-shvets-3683040.jpg?itok=BGKnp3lV

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/2023-08/pexels-anna-shvets-3683040.jpg?itok=uz98Z00C

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/2023-08/pexels-anna-shvets-3683040.jpg?itok=gOc-yetz

Share

Thiazolidinediones (TZDs)

Latest Articles About TZDs